Skip to main content
Clinical Trials/NCT00636753
NCT00636753SuspendedNot Applicable

Antipsychotics and Metabolic Syndrome

Glostrup University Hospital, Copenhagen1 site in 1 country60 target enrollmentStarted: September 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Sponsor
Enrollment
60
Locations
1

Study Overview

Brief Summary

The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Gender male
  • Age 18-45
  • Debut drug-naive schizophrenics,
  • Caucasians
  • Consent given to take part in the project

Exclusion Criteria

  • Compliance-problems
  • Major lung-/kidney/hart/lever disorders
  • Abuse of alcohol/drugs
  • Diabetes 1 and 2
  • Antihypertensive
  • Anticholesterol-reducing medication
  • Patients under duress

Investigators

Sponsor
Glostrup University Hospital, Copenhagen
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Antipsychotics and Metabolic Syndrome | Clinical Trial